BVF Partners L P/il, 10% Owner at Capstone Therapeutics Corp. (CAPS), bought 954,250 shares at $0.25 ($239K) on 2011-07-29, disclosed to the SEC on 2011-08-01.
Open-market purchase of $239k CAPS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.25 | 5,950 | $1K | 0.6% |
| 2 | $0.25 | 17,100 | $4K | 1.8% |
| 3 | $0.25 | 120,700 | $30K | 12.6% |
| 4 | $0.25 | 212,000 | $53K | 22.2% |
| 5 | $0.25 | 598,500 | $150K | 62.7% |
| Total | $0.25 avg | 954,250 |
| $239K |
| 100% |
| Filing → |
| KYMR | BUY | 2022-05-31 | $8.3M | — | Filing → |
| IDYA | SELL | 2021-02-04 | $835K | — | Filing → |
| XOMA | BUY | 2020-03-27 | $284K | — | Filing → |